A 39-year-old woman with unilateral metamorphosias
Article Sidebar
Main Article Content
Abstract
A 39-year-old white woman presented to the Centro Hospitalar Vila Nova de Gaia with a chief symptom of blurred vision and metamorphopsias in the left eye of several days' duration. Her past medical history was unremarkable. She was not taking any medications. She was a nonsmoker, did not use alcohol, and had no pets. Her family history was unremarkable except for her mother having hypertension.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Neri P. New Trends in the management of inflammatory choroidal neovascularisation. European Ophthalmic Review 2009;3:93-7. DOI: https://doi.org/10.17925/EOR.2009.03.02.93
Essex R, Wong J, Fraser-Bell S, Sandbach J, Tufail A, Bird A, Dowler J. Punctate inner choroidopathy. Arch of Ophthalmol 2010;128:982-7. DOI: https://doi.org/10.1001/archophthalmol.2010.157
Watzke R, Packer A, Folk J, Benson W, Burgess D, Ober R. Punctate inner choroidopathy. Am J Ophthalmol 1984;98:572-84. DOI: https://doi.org/10.1016/0002-9394(84)90243-5
Amer R, Lois N. Punctate inner choroidopathy. Surv Ophthalmol 2011;56:36-53. DOI: https://doi.org/10.1016/j.survophthal.2010.03.009
Gerstenblith A, Thorne J, Sobrin L, Do D, Shah S, Foster S, Jacobs D, Nguyen Q. Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology 2007;114:1201-4. DOI: https://doi.org/10.1016/j.ophtha.2006.10.047
Brown J, Folk J, Reddy C, Kimura A. Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome Ophthalmol 1996;103:1100-5. DOI: https://doi.org/10.1016/S0161-6420(96)30561-7
Menezo V, Cuthbertson F, Susan D. Positive response to intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to punctate inner choroidopathy. Retina 2010;30. [Epub ahead of print] DOI: https://doi.org/10.1097/IAE.0b013e3181d374dc
Brueggeman R, Noffke A, Jampol L. Resolution of punctuate inner choroidopathy lesions with oral prednisone therapy. Arch Ophthalmol 2002; 120:996. DOI: https://doi.org/10.1001/archopht.120.7.996
Levy J, Shneck M, Klemperer I, Lifshitz T. Punctate inner choroidopathy: resolution after oral steroid treatment and review of the literature. Can J Ophthalmol 2005;40:605-8. DOI: https://doi.org/10.1016/S0008-4182(05)80053-5
Sim D, Sheth H, Kaines A, Tufail A. Punctate inner choroidopathy-associated choroidal neovascular membranes during pregnancy. Eye 2008;22:725-7. DOI: https://doi.org/10.1038/eye.2008.93
Cirino A, Mathura J, Jampol L. Resolution of activity (choroiditis and choroidal neovascularization) of chronic recurrent punctate inner choroidopathy after treatment with interferon B-1A. Retina 2006;26:1091-2. DOI: https://doi.org/10.1097/01.iae.0000254891.48272.13
Olsen TW, Capone A Jr, Sternberg P Jr, Grossniklaus HE, Martin DF, Aaberg TM Sr. Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical managment and pathological findings. Ophthalmol 1996;103:2061-9. DOI: https://doi.org/10.1016/S0161-6420(96)30387-4
Chatterjee S, Gibson J. Photodynamic therapy: a treatment option in choroidal neovascularisation secondary to punctate inner choroidopathy. Br J Ophthalmol 2003;87:925-7. DOI: https://doi.org/10.1136/bjo.87.7.925-a
Chan WM, Lai T, Liu D, Lam D. Intravitreal Bevacizumab (Avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy or of idiopathic origin. Am J Ophthalmol 2007; 143: 977-83. DOI: https://doi.org/10.1016/j.ajo.2007.02.039
Vossmerbaeumer U, Spandau U, Baltz S, Wickenhaeuser A, Jonas J. Intravitreal bevacizumab for choroidal neovascularisation secondary to punctate inner choroidopathy. Clin Experiment Ophthalmol 2008;36:292-4. DOI: https://doi.org/10.1111/j.1442-9071.2008.01727.x
Kramer M, Axer-Siegel R, Jaouni T, Reich E, Hemo I, Priel E, Averbukh E, Ehrlich R, Chowers I, Weinberger D, Amer R. Bevacizumab for choroidal neovascularization related to inflammatory diseases. Retina 2010;30:938-44. DOI: https://doi.org/10.1097/IAE.0b013e3181c96a00
Spiteri Cornish K, William GJ, Gavin MP, Imrie FR. Visual and optical coherence tomography outcomes of intravitreal bevacizumab and ranibizumab in inflammatory choroidal neovascularization secondary to punctuate inner choroidopathy. Eur J Ophthalmol 2011; 21:440-5. DOI: https://doi.org/10.5301/EJO.2010.6117